Published: Jan 22, 2026 Category Happenings Source https://arci.org/resource/attr-amyloidosis-clinical-trials/ Kristen Hsu, ARC’s Executive Director of Research, shared the latest updates on ATTR (transthyretin amyloidosis) clinical trials and what these developments mean for patients and families. There was also an opportunity for questions and answers.
